Literature DB >> 17055292

Adaptations of intestinal macrophages to an antigen-rich environment.

Mirjam Schenk1, Christoph Mueller.   

Abstract

Intestinal macrophages, preferentially located in the subepithelial lamina propria, represent in humans the largest pool of tissue macrophages. To comply with their main task, i.e. the efficient removal of microbes and particulate matter that might have gained access to the mucosa from the intestinal lumen while maintaining local tissue homeostasis, several phenotypic and functional adaptations evolved. Most notably, microbe-associated molecular pattern (MAMP) receptors, including the lipopolysaccharide receptors CD14 and TLR4, but also the Fc receptors for IgA and IgG are absent on most intestinal Mø. Here we review recent findings on the phenotypic and functional adaptations of intestinal Mø and their implications for the pathogenesis of inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055292     DOI: 10.1016/j.smim.2006.09.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  25 in total

Review 1.  Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis.

Authors:  B M Buchholz; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-03       Impact factor: 3.598

Review 2.  Intestinal macrophages: differentiation and involvement in intestinal immunopathologies.

Authors:  Benjamin Weber; Leslie Saurer; Christoph Mueller
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 3.  The mucosal firewalls against commensal intestinal microbes.

Authors:  Andrew J Macpherson; Emma Slack; Markus B Geuking; Kathy D McCoy
Journal:  Semin Immunopathol       Date:  2009-08-26       Impact factor: 9.623

4.  Different antigen presentation tendencies of granulocyte-macrophage colony-stimulating factor-induced bone marrow-derived macrophages and peritoneal macrophages.

Authors:  Maozhi Hu; Zhiming Pan; Yun Yang; Chuang Meng; Shizhong Geng; Meng You; Xinan Jiao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-07-18       Impact factor: 2.416

Review 5.  Protective and pro-inflammatory roles of intestinal bacteria.

Authors:  Cynthia Reinoso Webb; Iurii Koboziev; Kathryn L Furr; Matthew B Grisham
Journal:  Pathophysiology       Date:  2016-02-17

6.  Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease.

Authors:  Bakytzhan Bakhautdin; Maria Febbraio; Esen Goksoy; Carol A de la Motte; Muhammet F Gulen; Erin Patricia Childers; Stanley L Hazen; Xiaoxia Li; Paul L Fox
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

Review 7.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

Review 8.  Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.

Authors:  Zejun Zhou; Miao Ding; Lei Huang; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2016-09-09       Impact factor: 3.969

9.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

10.  Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii.

Authors:  Ildiko R Dunay; Renato A Damatta; Blima Fux; Rachel Presti; Suellen Greco; Marco Colonna; L David Sibley
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.